Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis.

Han, Yi-Ran; Wang, Tian-Hao; Gong, Wen-Ping; Liang, Jian-Qin; An, Hui-Ru

Han, Yi-Ran; Wang, Tian-Hao; Gong, Wen-Ping; Liang, Jian-Qin; An, Hui-Ru.

Afiliação

Han YR; Department of Tuberculosis, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, Beijing, 100091, People's Republic of China.
Wang TH; Department of Emergency, The Eighth Medical Center of PLA General Hospital, Beijing, 100091, People's Republic of China.
Gong WP; Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute for Tuberculosis Research, Senior Department of Tuberculosis, The 8th Medical Center of Chinese PLA General Hospital in China, Beijing, 100091, People's Rep
Liang JQ; Department of Tuberculosis, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, Beijing, 100091, People's Republic of China.
An HR; Department of Tuberculosis, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, Beijing, 100091, People's Republic of China.

Ther Clin Risk Manag ; 18: 287-298, 2022.

Article em En | MEDLINE | ID: mdl-35386182

Palavras-chave

drug resistance; immunity; meta-analysis; pulmonary TB; thymopentin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Ther Clin Risk Manag Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google